# Hospital Consolidation **Hospital consolidation** is the decades-long trend of hospitals merging into larger systems and chains. It concentrates market power and gives systems leverage over the prices commercial insurers pay. It connects to [[For-Profit Hospital]] economics, [[Vertical Integration]] into physician practices, and the contraction stories at [[Community Health Systems]] and [[Tenet Healthcare]]. See [[Healthcare Industry Ecosystem]]. ## How much - **1,577 hospital mergers from 1998 to 2017**, and 261 more in 2018–20 (economist Martin Gaynor, Senate testimony, 2021). - **2025:** 46 announced deals, fewer than in 2024, but a record **43.5%** involved a financially distressed party (Kaufman Hall). Consolidation now often means a struggling hospital being absorbed rather than two healthy ones combining. - **The big three for-profits**, HCA, Tenet and CHS, hold about 8% of community hospital beds (KFF, 2022). The vault previously said "the 17 largest for-profit systems control nearly 30% of non-federal hospitals"; no source for that figure could be found, so it has been dropped here. ## What it does to prices | Finding | Source | |---|---| | A monopoly hospital charges about **12%** more than one with three or more competitors | Cooper, Craig, Gaynor & Van Reenen, "The Price Ain't Right" (2019) | | A merger between hospitals within five miles of each other raises prices about **6%** | same | | A merger between hospitals in different markets but the same state raises prices **7–9%** | Dafny, Ho & Lee (2019) | | A hospital buying physician practices raises their prices about **14%** | Capps et al. (2018), cited by Gaynor | The cross-market finding matters most for policy. Antitrust review has looked mainly at deals between nearby rivals, so mergers across a state, where the leverage comes from bargaining with insurers over a whole network, have rarely been challenged. ## Enforcement - **Novant–CHS (2024).** The [[FTC]] sued to block Novant Health's $320M purchase of two North Carolina hospitals. It lost in district court, then won an injunction from the Fourth Circuit pending appeal, and the deal was abandoned on July 1, 2024. - **Under [[Andrew Ferguson]] (2025–26).** In March 2025 the FTC voted 4–0 to oppose Indiana's request to shield the Union Health–Terre Haute Regional merger through a certificate of public advantage (COPA), a state grant of antitrust immunity. Indiana approved it anyway in November 2025, with price caps, over the objection of its own attorney general. Nineteen states allow COPAs (one source). In June 2026 the FTC required Ascension to sell seven surgery centers as a condition of its $3.9B purchase of AmSurg. - **Payment policy.** EO 14221 (February 2025) pushed price transparency. In November 2025 CMS finalized "site-neutral" payment for drug administration at off-campus hospital outpatient departments, a 60% cut from 2026 that targets one of the main financial reasons hospitals buy physician practices. ## See Also - [[Healthcare Industry Ecosystem]] · [[For-Profit Hospital]] · [[Private Equity Hospital Rollup]] · [[Steward Health Care]] - [[HCA Healthcare]] · [[Tenet Healthcare]] · [[Community Health Systems]] · [[Healthcare Lexicon]] - [[Antitrust]] · [[Vertical Integration]] · [[FTC]]